M. Bonnet, M. Dermu, Clara Roessle, M. Bellaiche, T. Abarou, V. Vasseur, Samira Benakouche, T. Storme
{"title":"3个月稳定口服粘性布地奈德凝胶的配方和指示稳定性的高效液相色谱方法的开发","authors":"M. Bonnet, M. Dermu, Clara Roessle, M. Bellaiche, T. Abarou, V. Vasseur, Samira Benakouche, T. Storme","doi":"10.1515/PTHP-2018-9005","DOIUrl":null,"url":null,"abstract":"Corrigendum to: Mathilde Bonnet, Marine Dermu, Clara Roessle, Marc Bellaiche, Tarik Abarou, Véronique Vasseur, Samira Benakouche and Thomas Storme. Formulation of a 3-months Stability Oral Viscous Budesonide Gel and Development of an Indicating Stability HPLC Method. Pharmaceutical Technology in Hospital Pharmacy. Volume 3, Issue 2, pages 91–99. (DOI https://doi.org/10.1515/pthp2018-0005) In Table 1, on page 94, the formulation was based on the original formula published by Eyal Zur, compounding pharmacist and consultant from Israel, in the International Journal of Pharmaceutical Coupounding in 2012. [1]","PeriodicalId":19802,"journal":{"name":"Pharmaceutical Technology in Hospital Pharmacy","volume":"1 1","pages":"47 - 47"},"PeriodicalIF":0.0000,"publicationDate":"2019-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Corrigendum to: Formulation of a 3-months Stability Oral Viscous Budesonide Gel and Development of an Indicating Stability HPLC Method\",\"authors\":\"M. Bonnet, M. Dermu, Clara Roessle, M. Bellaiche, T. Abarou, V. Vasseur, Samira Benakouche, T. Storme\",\"doi\":\"10.1515/PTHP-2018-9005\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Corrigendum to: Mathilde Bonnet, Marine Dermu, Clara Roessle, Marc Bellaiche, Tarik Abarou, Véronique Vasseur, Samira Benakouche and Thomas Storme. Formulation of a 3-months Stability Oral Viscous Budesonide Gel and Development of an Indicating Stability HPLC Method. Pharmaceutical Technology in Hospital Pharmacy. Volume 3, Issue 2, pages 91–99. (DOI https://doi.org/10.1515/pthp2018-0005) In Table 1, on page 94, the formulation was based on the original formula published by Eyal Zur, compounding pharmacist and consultant from Israel, in the International Journal of Pharmaceutical Coupounding in 2012. [1]\",\"PeriodicalId\":19802,\"journal\":{\"name\":\"Pharmaceutical Technology in Hospital Pharmacy\",\"volume\":\"1 1\",\"pages\":\"47 - 47\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pharmaceutical Technology in Hospital Pharmacy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1515/PTHP-2018-9005\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmaceutical Technology in Hospital Pharmacy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1515/PTHP-2018-9005","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
更正:Mathilde Bonnet, Marine Dermu, Clara Roessle, Marc Bellaiche, Tarik Abarou, v尼克·瓦瑟尔，Samira Benakouche和Thomas Storme。3个月稳定口服粘性布地奈德凝胶的制备及指示稳定性高效液相色谱法的建立。医院药房的制药技术第三卷，第2期，第91-99页。(DOI https://doi.org/10.1515/pthp2018-0005)在第94页的表1中，该配方基于以色列复方药剂师和顾问Eyal Zur于2012年在《国际药物配药杂志》上发表的原始配方。[1]
Corrigendum to: Formulation of a 3-months Stability Oral Viscous Budesonide Gel and Development of an Indicating Stability HPLC Method
Corrigendum to: Mathilde Bonnet, Marine Dermu, Clara Roessle, Marc Bellaiche, Tarik Abarou, Véronique Vasseur, Samira Benakouche and Thomas Storme. Formulation of a 3-months Stability Oral Viscous Budesonide Gel and Development of an Indicating Stability HPLC Method. Pharmaceutical Technology in Hospital Pharmacy. Volume 3, Issue 2, pages 91–99. (DOI https://doi.org/10.1515/pthp2018-0005) In Table 1, on page 94, the formulation was based on the original formula published by Eyal Zur, compounding pharmacist and consultant from Israel, in the International Journal of Pharmaceutical Coupounding in 2012. [1]
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
